From: The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
Disease activity measure | |
1 | Tender joint count |
2 | Swollen joint count |
3 | Patient’s assessment of pain |
4 | Patient’s global assessment of disease activity |
5 | Physician’s assessment of physical function |
6 | Patient’s assessment of physical function |
7 | Acute-phase reactant value |
For trial duration ≥1 year and agent being tested as a ‘DMARD’, also perform: | |
8 | Radiography or other imaging technique |